NDC 68071-2928-01 - Nitrofurantoin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-2928
- Requested NDC
- 68071-2928-01
- Package NDCs from labels
- 68071-2928-4, 68071-2928-6, 68071-2928-2, 68071-2928-1, 68071-2928-01
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Effective date
- 2026-09-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Nitrofurantoin Capsules USP (Monohydrate/Macrocrystals) | NuCare Pharmaceuticals,Inc. | 2026-09-22 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-2928-4 | Nitrofurantoin | 14 in 1 BOTTLE | CAPSULE | 14 | 3 | |
| 68071-2928-6 | Nitrofurantoin | 6 in 1 BOTTLE | CAPSULE | 6 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-2928 | NITROFURANTOIN CAPSULE [NUCARE PHARMACEUTICALS,INC.] | 3 | Current NDC, 2 package rows | 20231021_f40af3e1-e54c-3a35-e053-2a95a90a6cb2.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nitrofurantoin | NITROFURANTOIN | Somerset Therapeutics, LLC | dd99ba40-edff-47c3-9ee4-7e5b7774e5b5 | 2026-01-22 | Warnings, Adverse reactions | 927AH8112L |
| Nitrofurantoin (monohydrate/macrocrystals) | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | Preferred Pharmaceuticals Inc. | 11e8f91c-5712-4267-9956-e619d081d1f4 | 2026-01-16 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| NITROFURANTOIN | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | A-S Medication Solutions | 2a772eb3-4fb3-4d92-b9f4-469dd2216361 | 2026-01-06 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| Nitrofurantoin (monohydrate/macrocrystals) | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | PD-Rx Pharmaceuticals, Inc. | 7767697f-4dd0-477d-b5cc-e1ed5689f097 | 2026-01-05 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| Nitrofurantoin (monohydrate/macrocrystals) | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | PD-Rx Pharmaceuticals, Inc. | 643cdcff-8599-4326-b3ca-d9fd270e0fc2 | 2026-01-05 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| Nitrofurantoin (monohydrate/macrocrystals) | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | Northwind Health Company, LLC | 04b4189e-9b21-78ed-e063-6394a90ab8e0 | 2026-01-01 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| nitrofurantoin macrocrystals | NITROFURANTOIN MACROCRYSTALS | Northwind Health Company, LLC | 075fe819-fc4f-2dce-e063-6294a90ad823 | 2025-12-26 | Warnings, Adverse reactions | 927AH8112L |
| Nitrofurantoin Macrocrystals | NITROFURANTOIN MACROCRYSTALS | Redpharm Drug | 32520c80-0ce5-ea4b-e063-6294a90a37ba | 2025-12-18 | Warnings, Adverse reactions | 927AH8112L |
| Nitrofurantoin (monohydrate/macrocrystals) | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | QPharma, Inc. | fbc05ccb-782b-55f6-e053-6394a90a7fd6 | 2025-12-16 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| Nitrofurantoin (monohydrate/macrocrystals) | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | NuCare Pharmaceuticals,Inc. | 155c8d68-576e-f85c-e063-6294a90ada4b | 2025-12-10 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| NITROFURANTOIN (monohydrate/macrocrystals) | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | Redpharm Drug | 3dd034a6-8810-93f5-e063-6394a90a36c2 | 2025-12-02 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| NITROFURANTOIN (monohydrate/macrocrystals) | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | QPharma, Inc. | 055477be-e42c-fe8b-e063-6394a90a0449 | 2025-12-01 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| Nitrofurantoin | NITROFURANTOIN | Rising Pharma Holdings, Inc. | 89095f4d-e142-465e-b378-da24f6eeaf2b | 2025-11-11 | Warnings, Adverse reactions | 927AH8112L |
| nitrofurantoin macrocrystals | NITROFURANTOIN MACROCRYSTALS | VERITYRX, LLC | 42a1c744-93dc-31cc-e063-6294a90ab912 | 2025-11-02 | Warnings, Adverse reactions | 927AH8112L |
| Nitrofurantoin | NITROFURANTOIN | Bryant Ranch Prepack | 1c5db054-58af-4932-8fad-c3883b13f987 | 2025-10-22 | Warnings, Adverse reactions | ANDA208516 1648755 E1QI2CQQ1I 927AH8112L |
| Nitrofurantoin Monohydrate/ Macrocrystalline | NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE | Alvogen Inc. | 1a86deef-0887-43b1-bb96-dbc222b15931 | 2025-10-16 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| Macrobid | NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE | Almatica Pharma LLC | 8f270a9f-12a1-44d4-bc7e-873613555801 | 2025-10-14 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| NITROFURANTOIN | NITROFURANTOIN | Proficient Rx LP | 0819be0b-03e9-426e-a4b9-624c32958f94 | 2025-09-01 | Warnings, Adverse reactions | 927AH8112L |
| NITROFURANTOIN | NITROFURANTOIN | Camber Pharmaceuticals, Inc. | 4e06b31e-cc49-4526-beb6-e77021823aa9 | 2025-08-13 | Warnings, Adverse reactions | 927AH8112L |
| Nitrofurantoin | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | A-S Medication Solutions | b644426c-c8ba-4fe0-80c7-d9b2dde37395 | 2025-08-13 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.